U.S-South Africa Program for Collaborative Biomedical Research (U01)
The summary for the U.S-South Africa Program for Collaborative Biomedical Research (U01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
U.S-South Africa Program for Collaborative Biomedical Research (U01): The purpose of this Funding Opportunity Announcement (FOA) is to establish a new U.S.-South Africa Program for Collaborative Biomedical Research. Research areas supported under this program include TB, HIV/AIDS biomedical and behavioral science, and HIV-related co-morbidities, including malignancies. This opportunity is specifically designed to promote partnerships between eligible NIH intramural investigators (e.g. those conducting research within the laboratories and clinics of the NIH) and eligible South African investigators (e.g., those conducting research in eligible laboratories in South Africa).
Federal Grant Title: | U.S-South Africa Program for Collaborative Biomedical Research (U01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AI-14-018 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.855, 93.856, 93.865 |
CFDA Descriptions: | Allergy, Immunology and Transplantation Research; Microbiology and Infectious Diseases Research; Child Health and Human Development Extramural Research |
Current Application Deadline: | Apr 22, 2014 |
Original Application Deadline: | Apr 22, 2014 |
Posted Date: | Jan 24, 2014 |
Creation Date: | Jan 24, 2014 |
Archive Date: | May 23, 2014 |
Total Program Funding: | $600,000 |
Maximum Federal Grant Award: | $225,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Organizations); NIH Intramural Program
Non-domestic (non-U.S.) Entities (Foreign Institutions) from South Africa are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-018.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
- • Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...
- • Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center (...
- • Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)
- • Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scal...
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
- • Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
- • Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
- • NINDS Program Project Grant (P01 Clinical Trial Optional)
- • Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...